✦ LIBER ✦

Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: A 5-year study of patients with hepatitis B with lamivudine resistance

✍ Scribed by Fusao Ikeda; Nobuyuki Baba; Koichi Takaguchi; Junichi Kubota; Kenji Miyoshi; Shin-ichi Fujioka; Yuki Moritou; Yasuto Takeuchi; Tetsuya Yasunaka; Yasuhiro Miyake; Akinobu Takaki; Yoshiaki Iwasaki; Haruhiko Kobashi; Kazuhide Yamamoto

Book ID: 115559021
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 288 KB
Volume: 84
Category: Article
ISSN: 0146-6615
DOI: 10.1002/jmv.23371

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

740 Emergence of dual-resistance HBV mut

740 Emergence of dual-resistance HBV mutations to adefovir-dipivoxil and lamivudine in a hepatitis B patient with combination therapy for adefovir resistance

✍ S.Y. Kwon; C.H. Lee; W.H. Choi; J.E. Yeon; K.S. Byun 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Characteristics of adefovir resistance i

Characteristics of adefovir resistance in patients with or without lamivudine-resistant hepatitis B virus treated with adefovir: a 4-year experience

✍ Chien-Hung Chen; Jing-Houng Wang; Sheng-Nan Lu; Tsung-Hui Hu; Chao-Hung Hung; Mi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

Study on the Efficacy and Safety of Adef

Study on the Efficacy and Safety of Adefovir Dipivoxil Treatment in Post–Liver Transplant Patients With Hepatitis B Virus Infection and Lamivudine-Resistant Hepatitis B Virus

✍ R. Bárcena; S. Del Campo; G. Moraleda; T. Casanovas; M. Prieto; M. Buti; J.M. Mo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Early hepatitis B virus DNA reduction in

Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir

✍ Nancy Leung; Cheng-Yuan Peng; Hie-Won Hann; Jose Sollano; Judy Lao-Tan; Chao-Wei 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

This study was undertaken to compare the early antiviral activity and viral kinetic profiles of entecavir (ETV) versus adefovir (ADV) in hepatitis B e antigen positive nucleoside-naïve adults with chronic hepatitis B (CHB). Sixty-nine nucleoside-naïve CHB patients with baseline HBV DNA of 10(8) copi

438 Continued safety and efficacy of add

438 Continued safety and efficacy of adding adefovir dipivoxil (ADV) to ongoing lamivudine (LAM) therapy in compensated chronic hepatitis B (CHB) patients with YMDD variant HBV: 2 year results

✍ R. Perrillo; B. Willems; N. Leung; C. Trepo; H.W.L. Hann; G. Lau; W.M. Lee; E. S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A viral kinetic study using pegylated in

A viral kinetic study using pegylated interferon alpha 2B and lamivudine in naive patients with hepatitis B E antigen negative/hepatitis B virus DNA-positive chronic hepatitis B: Vana Sypsa Mrs, Athens Univ Medical Sch, Athens Greece; Nicolaos C Tassopoulos Mr, Western Attica General Hospital, Athens Greece; Dimitris Chrysagis Mr, Loimodon Hospital, Thessaloniki Greece; Maria Raptopoulou Mrs, Aristoteleion Univ of Thessaloniki, Thessaloniki Greece; Ioannis Ketikoglou Mr, Hippokration General Hospital, Athens Greece; Themistoklis Vassiliadis Mr, Hippokration General Hospital, Thessaloniki Greece; Catherina Haida Mrs, Dimitris Paraskevis Mr, Athens Univ Medical Sch, Athens Greece; Francois Lafleur Mr, Schering Plough, Kenilworth, NJ; Angelos Hatzakis Mr, Athens Univ Medical Sch, Athens Greece

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB